Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Morbidity and mortality weekly report
1997 • 5,358 citations
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
1980 • 1,607 citations
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
1988 • 760 citations
The VATER association
1973 • 619 citations
Chemically induced birth defects
1986 • 515 citations
Birth defects encyclopedia
1991 • 209 citations
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
1982 • 206 citations
Pharmacoepidemiology
1995 • 190 citations
Chemically induced birth defects
1994 • 104 citations
Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase
1983 • 103 citations
Lovastatin: A New Cholesterol‐Lowering Agent
1987 • 82 citations
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis.
1984 • 65 citations
Maternal Hyperlipidemia in Pregnancy
1994 • 59 citations
Lipoprotein Metabolism: Hormonal Regulation
1987 • 20 citations
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
1984 • 20 citations
Hypercholesterolemia
1990 • 10 citations
Anti-cholesterol agent pregnancy exposure outcomes
1994 • 8 citations
A color atlas of human embryology
1975 • 8 citations
Substance abuse services for pregnant women: the Buffalo experience
1994 • 2 citations